Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer.
Depierre A, Milleron B, Moro-Sibilot D, Chevret S, Quoix E, Lebeau B, Braun D, Breton JL, Lemarié E, Gouva S, Paillot N, Bréchot JM, Janicot H, Lebas FX, Terrioux P, Clavier J, Foucher P, Monchâtre M, Coëtmeur D, Level MC, Leclerc P, Blanchon F, Rodier JM, Thiberville L, Villeneuve A, Westeel V, Chastang C; French Thoracic Cooperative Group. Depierre A, et al. Among authors: blanchon f. J Clin Oncol. 2002 Jan 1;20(1):247-53. doi: 10.1200/JCO.2002.20.1.247. J Clin Oncol. 2002. PMID: 11773176 Clinical Trial.
[Treatment of non-small cell lung cancer (2003 update)].
Lavolé A, Blanchon F, Breton JL, Milleron B. Lavolé A, et al. Among authors: blanchon f. Rev Mal Respir. 2004 Feb;21(1):175-8. doi: 10.1016/s0761-8425(04)71255-3. Rev Mal Respir. 2004. PMID: 15260057 Review. French. No abstract available.
[IFCT-0302 trial: randomised study comparing two follow-up schedules in completely resected non-small cell lung cancer].
Westeel V, Lebitasy MP, Mercier M, Girard P, Barlesi F, Blanchon F, Tredaniel J, Bonnette P, Woronoff-Lemsi MC, Breton JL, Azarian R, Falcoz PE, Friard S, Geriniere L, Laporte S, Lemarie E, Quoix E, Zalcman G, Guigay J, Morin F, Milleron B, Depierre A; Intergroupe Francophone de Cancerologie Thoracique (IFCT). Westeel V, et al. Among authors: blanchon f. Rev Mal Respir. 2007 May;24(5):645-52. doi: 10.1016/s0761-8425(07)91135-3. Rev Mal Respir. 2007. PMID: 17519819 Clinical Trial. French.
Phase II trial of paclitaxel and carboplatin in metastatic small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie study.
Thomas P, Castelnau O, Paillotin D, Léna H, Robinet G, Muir JF, Delaval P, Gouva S, Balmes P, Blanchon F, Perdu D, Poirier R, Pommier De Santi P, Penot-Ragon C, Kleisbauer JP. Thomas P, et al. Among authors: blanchon f. J Clin Oncol. 2001 Mar 1;19(5):1320-5. doi: 10.1200/JCO.2001.19.5.1320. J Clin Oncol. 2001. PMID: 11230474 Clinical Trial.
[Primary lung cancer in elderly subjects in France].
Piquet J, Blanchon F, Grivaux M, Collon T, Zureik M, Barbieux H, Bénichou-Flurin M, Breton JL, Coëtmeur D, Delclaux B, Braun D, Homasson JP, Mouysset F, Riou R, le Poulain-Doubliez M, Marsal L; CPHG. Piquet J, et al. Among authors: blanchon f. Rev Mal Respir. 2004 Nov;21(5 Pt 3):8S70-8. Rev Mal Respir. 2004. PMID: 15803540 French.
Phase II randomized multicenter study evaluating a treatment regimen alternating docetaxel and cisplatin-vinorelbine with a cisplatin-vinorelbine control group in patients with stage IV non-small-cell lung cancer: GFPC 97.01 study.
Pérol M, Léna H, Thomas P, Robinet G, Fournel P, Coste E, Belleguic C, Le Caer H, Blanchon F, Vergnenègre A, Vernejoux JM, Schuller-Lebeau MP, Pham E. Pérol M, et al. Among authors: blanchon f. Ann Oncol. 2002 May;13(5):742-7. doi: 10.1093/annonc/mdf128. Ann Oncol. 2002. PMID: 12075743 Free article. Clinical Trial.
71 results